Terms: = Ovarian cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1 AND Treatment
2 results:
1. Disease-inducing potential of two leukemic cell lines in a xenografting model.
Manavella DD; Herraiz S; Soares M; Buigues A; Pellicer A; Donnez J; Díaz-García C; Dolmans MM
J Assist Reprod Genet; 2021 Jun; 38(6):1589-1600. PubMed ID: 33786735
[TBL] [Abstract] [Full Text] [Related]
2. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]